Dementia, quantitative neuroimaging, and apolipoprotein E genotype

American Journal of Neuroradiology

Volumn 21, Issue 10, 2000, Pages 1857-1868

  Bigler, E D ^a   Lowry, C M ^a   Anderson, C V ^a   Johnson, S C ^a   Terry, J ^a   Steed, M ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEURORADIOLOGY; POLYMERASE CHAIN REACTION; QUANTITATIVE DIAGNOSIS;

AGED; AGED, 80 AND OVER; ALGORITHMS; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; ATROPHY; BRAIN; COGNITION DISORDERS; DEMENTIA; FEMALE; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE;

EID: 0033731232     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
2. The incidence of dementia: A meta-analysis
3. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease
4. Quantitative MR volumetry in Alzheimer's disease
5. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease
6. Differences in neuropsychological functioning associated with age, education, neurological status, and magnetic resonance imaging findings in neurologically healthy elderly individuals
7. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices
8. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease
9. Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: An MR volumetry study in Alzheimer's disease
10. Diagnostic challenges in dementia
11. Quantitative volumetric analysis of brain MR: Normative database spanning five decades of life
12. Hippocampal volume in normal aging and traumatic brain injury
13. The prevalence of whitematter lesions on computed tomography of the brain in demented and nondemented 85-year-olds
14. Brain volume preserved in healthy elderly through the eleventh decade
15. Declarative and procedural learning, quantitative measures of the hippocampus, and subcortical white alterations in Alzheimer's disease and ischaemic vascular dementia
16. The influence of white matter lesions on neuropsychological functioning in demented and non-demented 85-year-olds
17. Apolipoprotein E in cerebrospinal fluid in 85-year-old subjects
18. Alzheimer disease: When and why?
19. Apolipoprotein E ε4 allele and familial aggregation of Alzheimer disease
20. Apolipoprotein E ε4 allele and whole brain atrophy in late-onset Alzheimer's disease
21. Apolipoprotein E phenotypes, dementia, and mortality in a prospective population sample
22. Relationship between ApoE, MRI findings, and cognitive function in the cardiovascular health study
23. Risk of Alzheimer disease with the ε4 allele for apolipoprotein E in a population-based study of men aged 62-73 years
24. Apolipoprotein ε4 promotes incipient alzheimer pathology in the elderly
25. Clinicopathologic studies in cognitively healthy aging and Alzheimer disease
26. Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia
27. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
28. Genetic studies on chromosome 12 in late-onset Alzheimer disease
29. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease
30. Effects of apolipoprotein E on dementia and aging in the Shanghai survey of dementia
31. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity
32. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease
33. Apolipoprotein E and Alzheimer's disease
34. A population based study of APOE, Alzheimer's disease and quantitative magnetic resonance imaging
35. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
36. Apolipoprotein E ε4 allele, temporal lobe atrophy, and white matter lesions in latelife dementias
37. MRI volumetric study of dementia with Lewy bodies: A comparison with AD and vascular dementia
38. SPECT and MRI analysis in Alzheimer's disease: Relation to apolipoprotein E ε4 allele
39. Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes
40. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele
41. Apolipoprotein E, memory and Alzheimer's disease
42. APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD
43. Apolipoprotein E ε4 and hippocampal volume in twins with normal cognition
44. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E ε4 allele
45. Lack of association of apolipoprotein E ε4 allele dose with cerebral glucose metabolism in Alzheimer disease
46. Absence of an apolipoprotein E ε4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease
47. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E
48. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease
49. MRI temporal lobe volume measures and neuropsychological function in Alzheimer's disease
50. APOE-ε4 count predicts age when prevalence of AD increases, then declines: The Cache County study
51. Dementia diagnoses from clinical and neuropsychological date compared: The Cache County study
52. Mild cognitive impairment: Clinical characterization and outcome
53. Association of apolipoprotein E allele ε4 with late onset familial and sporadic Alzheimer's disease
54. The modified Mini-Mental State (3MS) Examination
55. Performance characteristics of a two-stage dementia screen in a population sample
56. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of Health and Human Services task force on Alzheimer's disease
57. Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop
58. The I role of APOEε4 in modulating effects of other risk factors for cognitive decline in elderly persons
59. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment
60. APOE-ε4 is associated with memory decline in cognitively impaired elderly
61. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
62. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
63. MRI-based hippocampal volumetrics: Data acquisition, normal ranges, and optimal protocol
64. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease
65. APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome
66. Mild cognitive impairment raises Alzheimer disease risk
67. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease
68. Quantitative evidence for neuroanatomic and neuropsychological markers in dementia of the Alzheimer's type
69. Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease
70. Aging of the brain and its impact on cognitive performance: Integration of structural and functional findings
71. Volumetry of the hippocampus and amygdala with magnetic imaging
72. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age
73. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
74. Alterations in apoliporotein E expression during aging and neurodegeneration
75. Episodic memory changes are associated with the apoE-ε4 allele in nondemented older adults
76. Preclinical memory decline in cognitively normal apolipoprotein E-ε4 homozygotes
77. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects
78. Variation in hippocampal neuron number with age and brain volume
79. Proton MR spectroscopic findings correspond to neuropsychological function in traumatic brain injury
80. Differential dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer's disease
81. Cortical variability and asymmetry in normal aging and Alzheimer's disease
82. A quantitative analysis of CT and cognitive measures in normal aging and Alzheimer's disease
83. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval
84. Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning
85. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease
86. Increased amyloid B-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease
87. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
88. Apolipoprotein E, dementia, and cortical deposition of B-amyloid protein
89. APOE genotype as a risk factor for ischemic cerebrovascular disease
90. Linkage studies in familial Alzheimer's disease: Evidence for chromosome 19 linkage
91. Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease
92. Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study